Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interactionCHEMICAL COMMUNICATIONSIF4.22024-01-010OAAI
The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis用于预防癌症转移的有效,竞争性CXCR4拮抗剂的开发BIOCHEMICAL PHARMACOLOGYIF5.62023-12-016OAAI
Junctions in DNA: underexplored targets for therapeutic interventionDNA中的连接: 治疗干预的未开发目标BIOORGANIC & MEDICINAL CHEMISTRYIF32022-09-0119OAAI
Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 ReceptorsMOLECULAR PHARMACOLOGYIF32022-01-0112OAAI
Peptide directed phthalocyanine-gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancersRSC MEDICINAL CHEMISTRYIF3.62021-01-0112OAAI
A Peptide-Duocarmycin Conjugate Targeting the Thomsen-Friedenreich Antigen Has Potent and Selective Antitumor ActivityBIOCONJUGATE CHEMISTRYIF3.92020-06-098OAAI
Identification of selective protein-protein interaction inhibitors using efficient in silico peptide-directed ligand design (vol 10, pg 4502, 2019)CHEMICAL SCIENCEIF7.42019-01-010OAAI
Identification of selective protein-protein interaction inhibitors using efficient in silico peptide-directed ligand designCHEMICAL SCIENCEIF7.42019-01-0116OAAI
Cytotoxicity of Pyrazine-Based Cyclometalated (C∧NPZ∧C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological PropertiesINORGANIC CHEMISTRYIF4.72017-04-2559OAAI